Last $43.15 USD
Change Today +0.30 / 0.70%
Volume 2.0M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glaxosmithkline plc-spon adr (GSK)

GlaxoSmithKline plc may have more financial risk than other companies in the Pharmaceuticals industry. It remains one of the most highly leveraged, despite its Debt to Total Capital ratio shrinking to 70.02% over the last fiscal year. However, an examination of near-term assets and liabilities shows that, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 55.64 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 179.00 days.
View Balance Sheet In British Pound
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
USD
Dec 31
2011
Restated
USD
Dec 31
2012
Restated
USD
Dec 31
2013
USD
4 Year
Trend
Assets    
Cash and Equivalents9,423.58,889.86,509.58,609.8
Short-Term Investments286.3286.3126.0102.7
Trading Asset Securities144.7--35.8--
TOTAL CASH AND SHORT TERM INVESTMENTS9,854.49,176.16,671.38,712.5
Accounts Receivable7,354.36,909.36,402.16,170.3
Notes Receivable77.863.862.257.6
Other Receivables1,266.41,303.81,408.01,988.3
TOTAL RECEIVABLES8,698.58,276.97,872.38,216.2
Inventory5,969.66,025.66,175.06,067.6
Prepaid Expenses398.3527.4441.8451.2
Other Current Assets28.01,146.6141.6242.7
TOTAL CURRENT ASSETS24,948.825,152.621,302.023,690.2
Gross Property Plant and Equipment28,460.228,292.228,412.028,533.4
Accumulated Depreciation-14,388.0-14,682.1-14,758.3-14,730.3
NET PROPERTY PLANT AND EQUIPMENT14,072.213,610.113,653.713,803.1
Goodwill5,610.25,840.56,781.76,542.1
Long-Term Investments2,938.91,921.42,209.22,374.2
Deferred Tax Assets, Long Term3,992.24,432.53,719.93,242.3
Other Intangibles13,274.112,138.415,808.514,442.5
Other Long-Term Assets865.0816.81,061.11,383.1
TOTAL ASSETS65,701.463,912.364,536.165,477.4
    
LIABILITIES & EQUITY    
Accounts Payable3,331.03,995.34,147.84,261.3
Accrued Expenses4,276.94,325.16,091.06,422.3
Short-Term Borrowings389.0169.63,152.12,791.1
Current Portion of Long-Term Debt/Capital Lease63.84,028.02,497.11,548.0
Current Portion of Capital Lease Obligations49.852.942.042.0
Current Income Taxes Payable1,628.92,556.22,137.72,259.0
Other Current Liabilities, Total10,106.58,219.33,215.83,737.0
Unearned Revenue, Current108.959.1252.0259.8
TOTAL CURRENT LIABILITIES19,904.923,352.621,493.421,278.7
Long-Term Debt22,929.418,890.522,748.923,964.0
Capital Leases110.594.976.282.5
Minority Interest1,334.91,236.91,457.81,268.0
Pension & Other Post-Retirement Benefits4,157.14,809.04,855.73,405.6
Deferred Tax Liability Non-Current1,100.01,278.91,562.01,078.2
Other Non-Current Liabilities2,338.41,753.43,318.53,514.6
TOTAL LIABILITIES50,540.250,179.254,054.753,323.5
Common Stock2,206.12,157.92,098.82,078.5
Additional Paid in Capital2,221.72,602.93,145.84,037.3
Retained Earnings5,398.63,611.0-317.4508.7
Comprehensive Income and Other4,000.04,124.44,096.44,261.3
TOTAL COMMON EQUITY13,826.412,496.29,023.610,885.9
TOTAL EQUITY15,161.313,733.010,481.412,153.9
TOTAL LIABILITIES AND EQUITY65,701.463,912.364,536.165,477.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $43.15 USD +0.30

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $166.26 USD -0.70
AbbVie Inc $66.98 USD +0.77
Biogen Idec Inc $342.40 USD +1.51
Celgene Corp $113.35 USD +3.75
Novo Nordisk A/S kr260.80 DKK -6.40
View Industry Companies
 

Industry Analysis

GSK

Industry Average

Valuation GSK Industry Range
Price/Earnings 15.5x
Price/Sales 2.7x
Price/Book 12.7x
Price/Cash Flow 15.4x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.